Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
September 10, 2019
Celyad Announces Launch of Proposed Global Offering
MONT-SAINT-GUIBERT, Belgium, Sept. 10, 2019 (GLOBE NEWSWIRE) -- Celyad (Euronext Brussels and Paris, and Nasdaq: CYAD), a clinical-stage biopharmaceutical company focused on the development of ...
September 9, 2019
Altimmune Appoints M. Scott Harris, M.D. as Chief Medical Officer
GAITHERSBURG, Md., Sept. 09, 2019 (GLOBE NEWSWIRE) -- Altimmune, Inc. (ALT), a clinical-stage biopharmaceutical company, today announced it has appointed M. Scott Harris, M.D. as ...
September 9, 2019
ProQR Receives Fast Track Designation from FDA for QR-1123 for Autosomal Dominant Retinitis Pigmentosa
LEIDEN, Netherlands and CAMBRIDGE, Mass., Sept. 09, 2019 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (PRQR), a company dedicated to changing lives through the creation of transformative RNA medicines for ...
September 9, 2019
Theravance Biopharma Reports Positive Results from Phase 1 Clinical Trial of TD-8236, an Investigational, Lung-Selective, Inhaled Pan-Janus Kinase (JAK) Inhibitor for Inflammatory Lung Diseases
DUBLIN, Sept. 9, 2019 /PRNewswire/ -- Theravance Biopharma, Inc. (TBPH) ("Theravance Biopharma" or the "Company") today announced initial results, including positive biomarker responses, from its Phase ...
September 9, 2019
Mustang Bio to Present at Scientific Conferences in September 2019
NEW YORK, Sept. 09, 2019 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell ...
September 9, 2019
Zogenix Completes Acquisition of Modis Therapeutics, Inc.
EMERYVILLE, Calif., Sept. 09, 2019 (GLOBE NEWSWIRE) -- Zogenix, Inc. (ZGNX), a global pharmaceutical company developing rare disease therapies, today announced that it has successfully ...
September 9, 2019
Paratek Mourns Passing of Co-founder Dr. Stuart Levy
BOSTON, Sept. 09, 2019 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (PRTK) mourns the loss of Stuart Levy, M.D., who passed way last week. Dr. Levy ...
September 9, 2019
TYME Presents Positive Circulating Tumor Cell Data from TYME-88-Panc Study in Patients with Advanced Pancreatic Cancer at AACR PANC 2019
NEW YORK, Sept. 09, 2019 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (TYME), an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs™), reported encouraging data on ...
September 9, 2019
Aileron Therapeutics Announces Management Change
WATERTOWN, Mass., Sept. 09, 2019 (GLOBE NEWSWIRE) -- Aileron Therapeutics (ALRN), the clinical-stage leader in the field of stabilized cell-permeating peptides to treat cancer and ...
September 9, 2019
InspireMD to Present at the HC Wainwright 21st Annual Global Investment Conference
TEL AVIV, Israel, Sept. 09, 2019 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention ...
September 9, 2019
SkinTE Data to be Presented at the American Society of Plastic Surgeons 88th Annual Scientific Meeting
SALT LAKE CITY, Sept. 9, 2019 /PRNewswire/ -- PolarityTE, Inc. (PTE), a biotechnology company developing and commercializing regenerative tissue products and biomaterials, today announced that an abstract ...
September 9, 2019
Advaxis Reports Fiscal Third Quarter 2019 Financial Results and Provides Pipeline Update
PRINCETON, N.J.--(BUSINESS WIRE)--Advaxis, Inc. (ADXS), a clinical-stage biotechnology company focused on the discovery, development and commercialization of immunotherapy products, today announced an update on its ...
September 9, 2019
InspireMD Provides Business Update
TEL AVIV, Israel, Sept. 09, 2019 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), the developer of the CGuard™ Embolic Prevention System (EPS) for the ...
September 9, 2019
Arena Pharmaceuticals Presented New Patient-Reported Outcomes Data for Olorinab at the European Society of Neurogastroenterology & Motility NeuroGASTRO 2019 Meeting
SAN DIEGO, Sept. 9, 2019 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (ARNA) presented new patient-reported outcomes data for olorinab, an investigational, oral, peripherally acting, highly-selective, full agonist ...
September 9, 2019
NeuBase Therapeutics Hosting Key Opinion Leader Meeting on Huntington's Disease and PATrOL™-Enabled Therapy on September 16th
PITTSBURGH, Sept. 09, 2019 (GLOBE NEWSWIRE) -- NeuBase Therapeutics, Inc. (NASDAQ: NBSE) (“NeuBase” or the “Company”), a biotechnology company developing next-generation antisense therapies to address ...
September 9, 2019
DURECT Earns $10 Million Milestone Payment for Further Development of a Long-Acting Injectable HIV Investigational Product Utilizing DURECT's SABER® Technology
CUPERTINO, Calif., Sept. 9, 2019 /PRNewswire/ -- DURECT Corporation (DRRX) announced today that further development of a long-acting injectable HIV investigational product utilizing DURECT's SABER® technology ...
September 5, 2019
Successful Pollen Season Confirms ASIT biotech on Track for Phase III Results of gp-ASIT+™ in December 2019
ASIT biotech (ASIT.BR) (ASIT.BR) (ASIT - BE0974289218), a clinical stage biopharmaceutical company focused on the research, development and future commercialization of breakthrough allergy immunotherapy products, ...
September 5, 2019
Pixium Vision to Participate in Multiple Upcoming Industry Events
Paris, 5 September 2019 – 5:45 PM CEST - Pixium Vision (FR0011950641 - PIX), a bioelectronics company developing innovative bionic vision systems to enable patients ...
September 5, 2019
OSE Immunotherapeutics Reports First Half 2019 Results and Provides a Corporate Update
NANTES, France, Sept. 05, 2019 (GLOBE NEWSWIRE) -- OSE Immunotherapeutics (ISIN: FR0012127173; Euronext: OSE)today reported its consolidated half-year financial results as of June 30, 2019 ...
September 5, 2019
Chiasma Hosting Key Opinion Leader Meeting on Maintenance Therapy of Adult Patients with Acromegaly
WALTHAM, Mass., Sept. 05, 2019 (GLOBE NEWSWIRE) -- Chiasma, Inc. (CHMA), a clinical-stage biopharmaceutical company focused on improving the lives of patients with rare and ...
Page 10 of 169